Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • bharat_iyengar
    Member
    • Dec 2012
    • 20

    Cufflinks statistical model

    I needed a little help in understanding the abundance estimation by
    Cufflinks.
    Please refer to cufflinks supplementary methods.

    Let me reiterate some of the key points/definitions; for the sake of
    convenience of explanation.

    ρ(t) = abundance of transcript t
    α(t) = probability of choosing a transcript t
    [identified by abundance and length]
    β(g) = sum(α(t)) (t belongs to g) = probability of choosing a transcript from
    a locus g
    γ(t) = probability that chosen transcript has given abundance and length

    Question 1: Does that mean that a transcript is fully identified by its
    length and abundance ?

    Question 2: In the parameter estimation section, I didnt quite understand
    how MLE of β becomes X(g)/M.
    Shouldnt it be the solution of ∑ ∂(X(g).log(β(g)))/∂β(g) = 0 ?

    Question 3: I dont understand importance sampling method much, but is
    there an intuitive way of understanding how is γ estimated from input
    variable i.e. reads ?

    FPKM calculation has l(t) in denominator. Cufflinks should accept any
    SAM/BAM file regardless of whether its passed through Tophat. If I pass to
    cufflinks, the reads aligned to transcriptome (refseq), and I dont provide
    any annotations, then:

    Question 4: How is a locus designated ?
    Question 5: How is l(t) estimated for FPKM calculation; length of a
    transcript should be smaller than a locus?


    Finally, how can I use cufflinks without involving genome alignments !?

Latest Articles

Collapse

  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM
  • GATTACAT
    Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
    by GATTACAT
    Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
    07-01-2026, 11:43 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 10:26 AM
0 responses
11 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-07-2026, 11:05 AM
0 responses
33 views
0 reactions
Last Post SEQadmin2  
Working...